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T-cell development: A new marker of differentiation state
Christophe Benoist and Diane Mathis
Differentiation of T cells is a complicated affair and
there has been a dearth of markers that faithfully
reflect thymocyte phenotype. A new strategy based on
T-cell receptor gene sequencing has revealed a marker
that can be used to monitor thymocyte differentiation
with fidelity and without perturbation. 
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T-lymphocyte differentiation occurs primarily in the
thymus (reviewed in [1]), which is seeded by poorly char-
acterized T-cell progenitors that are unreactive to foreign
antigens. From the thymus emerge mature T cells that,
collectively, are capable of responding to a multitude of
antigens — recognized by the antigen-specific T-cell
receptor as peptides bound to major histocompatibility
complex (MHC) molecules. In between these two devel-
opmental stages, an elaborate program of differentiation
unfolds, accompanied by massive proliferation and death,
such that millions of cells are produced within the
thymus, but only a small fraction emigrates into the
peripheral circulation.
Pathways of thymocyte differentiation have generally
been traced by following the display of particular cell-
surface proteins. Chief amongst these are the CD4 and
CD8 co-receptor molecules, whose pattern of expression
defines a progression of thymocyte differentiation in three
stages: CD4–CD8– cells include the most immature T-cell
progenitors; these differentiate into CD4+CD8+ cells,
which constitute the bulk of thymocytes and are the first
to express the αβ T-cell receptor; fully mature CD4+CD8–
or CD4–CD8+ cells display the αβ T-cell receptor at high
levels, proliferate in response to antigen stimulation, and
exhibit either of the characteristic helper or cytotoxic
effector functions of T cells. This three-stage pathway has
been embellished to an almost baroque degree by further
detailing expression levels of the two co-receptors or by
monitoring the display of other cell-surface proteins. Nev-
ertheless, this pathway remains a useful simplification,
allowing the major events in the life of a thymocyte to be
situated easily.
Two critical events coincide with the transition of thymo-
cytes from being CD4+CD8+ to CD4+CD8– or CD4–CD8+
cells. In a process termed positive selection, the repertoire
of T cells is enriched for those capable of recognizing
foreign antigens in association with self-expressed MHC
molecules. In addition, cells must decide whether to
become CD4+ helper T cells which recognize antigens in
association with MHC class II molecules or CD8+ cyto-
toxic cells reactive to antigens bound to MHC class I com-
plexes, a process called lineage commitment. It is
generally agreed that the key to both of these events is the
interaction between αβ T-cell receptors expressed on a
differentiating thymocyte and MHC molecules displayed
on thymic stromal cells [2]. 
Beyond this agreement, however, controversy reigns.
There is no consensus on exactly which route a
CD4+CD8+ cell follows to become a CD4+CD8– or
CD4–CD8+ cell, or precisely when positive selection or
lineage commitment takes place, or what mechanisms are
involved in executing these events [3]. At the root of
many of the disagreements is the inadequacy of existing
differentiation markers — in particular, their inability to
trace transition events occurring over a timescale that is
short compared with the turnover of surface proteins. For
example, surface levels of CD4, CD8 and the αβ T-cell
receptor have generally been taken as indicators of posi-
tive selection and/or lineage commitment, but expression
of these molecules at the cell surface is far removed from
the transcriptional programs underlying differentiative
changes, and too much reliance on this parameter has
prompted faulty conclusions to be drawn more than once
in the past. Also, most attempts to experimentally verify
the differentiation status of a cell suggested by its surface
marker profile have involved purifications based on anti-
body engagement of the same markers, a process that
could easily disturb normal maturation. 
A way around this difficult problem has recently been
reported by Sant’Angelo et al. [4], who have used T-cell
receptor sequences as a marker of thymocyte differentia-
tion state. To reduce the heterogeneity of the T-cell
receptor repertoire, they began with a transgenic mouse
line that carries a functionally rearranged gene encoding
the T-cell receptor β chain, which was derived from a T-
cell hybridoma specific for a peptide of myelin basic
protein presented by MHC class II Au molecules. The T-
cell receptor α chain expressed by the hybridoma cells was
encoded by a rearranged gene with the juxtaposed vari-
able (V) and joining (J) segments Vα2.3 and Jα11. Thus,
the authors focused on the sequence of the randomly gen-
erated junctional regions of Vα2.3–Jα11 transcripts in the
T-cell receptor β transgenic mouse line. 
Both CD4+CD8– thymocytes and peripheral CD4+ lym-
phocytes showed a striking enrichment for the precise
junctional region sequence found in the T-cell receptor α
gene sequence of the hybridoma cells; in addition, these
two populations were depleted of out-of-frame junctional
sequences. There were no such sequence enrichments and
depletions in the Vα2.3–Jα11 junctional regions of imma-
ture CD4+CD8+TCRlo thymocytes, nor in CD4–CD8+ thy-
mocytes or peripheral CD8+ lymphocytes. The most likely
explanation therefore is that, in the presence of the appro-
priate MHC molecules, in this case MHC II Au, cells
expressing the transgene-encoded Vβ chain together with
the ‘parental’ Vα chain are efficiently positively selected
into the CD4 lineage. Thus, the authors have taken the
frequency of this particular junctional region in this T-cell
receptor β transgenic mouse line as a marker for positive
selection mediated by MHC class II molecules and as a
marker for CD4 or CD8 lineage commitment.
Sant’Angelo et al. [4] have used this marker to make three
points. First, they regarded their observation of the strik-
ing enrichment of a particular Vα–Jα junctional segment
during positive selection to be an indication of the impor-
tant role of thymic peptides in this process. Their reason-
ing was that X-ray crystallographic studies have repeatedly
demonstrated that the region of the T-cell receptor α
chain specified by the V–J junctional segment is in inti-
mate contact with the peptide component of the
MHC–peptide ligand [5]. A previous report from this
group used a similar approach to make the same point
about the importance of thymic peptides, although this
earlier study relied on T-cell receptor β transgenic mice
that had an artificially restricted complement of thymic
peptides [6]. The role of peptides in positive selection has
also been established by a number of other investigators
using a variety of strategies [7]. 
Second, the authors exploited the difference between
CD4+CD8– and CD4–CD8+ cells to chart the sometimes
tortuous thymocyte differentiation pathways. They took a
high frequency of the parental Vα2.3–Jα11 junction to be
a marker of the CD4+ lineage and a low frequency to be
indicative of the CD8+ lineage. It should be kept in mind
that cells yet to undergo positive selection, as well as
CD8+ cells, have the low-frequency phenotype, however,
and therefore lineage assignment may not always be quite
so straightforward. Their results were consistent with a
previously published scheme [8], and highlighted the fact
that surface levels of CD4 and CD8 can be poor indicators
of lineage commitment, as pointed out by others [9,10]. 
Third, Sant’Angelo et al. [4] made use of the difference
between CD4+CD8+TCRlo and CD4+CD8–TCRhi thy-
mocytes to determine when positive selection is first
evident. For this, they examined the various intermediate
populations defined on the basis of thymocyte size —
which varies according to proliferation and activation state
— and levels of CD4, CD8, TCR and CD69 (an early T-
cell activation marker closely associated with positive
selection). It was somewhat surprising to find signs of pos-
itive selection already in CD69–, large, CD4+CD8+ cells,
yet this observation is consistent with an earlier report
indicating that inducibility of CD69 gene expression,
rather than CD69 cell-surface expression, is an early
marker of positive selection [11]. So it seems that positive
selection happens rather early during the 3–4-day life span
of a CD4+CD8+ cell. It is noteworthy, however, that the
enrichment for parental junctional sequences at this early
CD4+CD8+ stage was far less striking than at the fully
mature CD4+CD8– stage, suggesting that the selection
process continues for days.
We have recently reported a second strategy for side-step-
ping the problems with existing thymocyte differentiation
markers [12]. Using homologous recombination in embry-
onic stem cells, we replaced the coding sequences of one
of the copies of the CD4 gene with a β-galactosidase
gene, thereby rendering β-galactosidase a faithful reporter
of CD4 gene activity. It was also a more immediate indi-
cator of CD4 gene activity than cell-surface CD4 levels,
being cytoplasmic and having a faster turnover rate than
CD4 itself. Thus, β-galactosidase expression could be
used to distinguish cells committed to the CD4+ or the
CD8+ lineage independent of surface levels of the two co-
receptors. This new marker was also useful in tracing
pathways of thymocyte differentiation and in re-examin-
ing some of the controversial issues related to CD4 and
CD8 lineage commitment.
Hopefully, the judicious use of markers such as those
described here, used singly or in combination, will stimu-
late progress in resolving still-contentious points related to
thymocyte positive selection and lineage commitment. Cer-
tainly, it’s about time we moved forward on these issues.
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If you found this dispatch interesting, you might also want
to read the December 1998 issue of
Current Opinion in
Cell Biology
which included the following reviews, edited
by Elaine Dzierzak and Fiona M Watt, on
Cell differentiation:
The self-renewing mechanism of stem cells in
the germline
Haifan Lin
Spermatogonial stem cells
Dirk G de Rooij and J Anton Grootegoed
Notes from some crypt watchers: the regulation of
renewal in the mouse intestinal epithelium
Thaddeus S Stappenbeck, Melissa H Wong, 
Jennifer R Saam, Indira U Mysorekar, Jeffrey I Gordon
Liver stem cells: a two compartment system
Malcolm Alison
Recent progress in identifying genes regulating
hematopoietic stem cell function and fate
Craig T Jordan and Gary Van Zant
Role of cytokines and extracellular matrix in the
regulation of haemopoietic stem cells
Anthony D Whetton and Elaine Spooncer
Plasticity and stem cells in the vertebrate 
nervous system
David Panchision, Thomas Hazel and Ron McKay
Cellular differentiation in the leaf
Jane A Langdale
the same issue also included the following
reviews, edited by Michael Glotzer and
Juergen Knoblich, on Cell multiplication:
Emerging mechanisms of eukaryotic DNA 
replication initiation
Janet Leatherwood
Mitotic DNA damage and replication checkpoints 
in yeast
Nicholas Rhind and Paul Russell
SCF and APC: the Yin and Yang of cell cycle regulated
proteolysis
Jan-Michael Peters
Sister chromatid cohesion in mitosis
Sue Biggins and Andrew W Murray
The full text of Current Opinion in Cell Biology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/cel
